Zusammenfassung
Erläutert werden alle relevanten Funktionstests mit ausführlicher Darstellung von Indikationen, Kontraindikationen, Nebenwirkungen, Testvorbereitung, Rahmenbedingungen, konkreten Handlungsanleitung der eigentlichen Testdurchführung sowie der Interpretation der Testergebnisse. Es werden immer konkrete Normbereiche und Cut-off-Werte angegeben, auch für besondere Situationen (Geschlecht, Alter, BMI, Pubertätsphasen, Zyklusphasen, akute Erkrankungen, Medikamente etc.). Ein besonderes Merkmal ist die Betonung der Testvorbereitung, -durchführung und -interpretation sowie des interdisziplinären Charakters. Dieses Kapitel fasst Parameter der Fettgewebsdysfunktion, Fettgewebshormone, anthropometrische Messgrößen und die Bioimpedanzanalyse zusammen.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Literatur
Longo DL, Fauci AS, Kasper DL, Hauser SL (2011) Harrison’s principles of internal medicine. McGraw-Hill Professional, Maidenhead
James WPT (1976) Research on obesity. Her Majesty’s Stationary Office, London
Hallynck TH, Soep HH, Thomis JA, Boelaert J, Daneels R, Dettli L (1981) Should clearance be normalised to body surface or to lean body mass? Br J Clin Pharmacol 11:523–526
Durnin JV, Womersley J (1974) Body fat assessed from total body density and its estimation from skinfold thickness: measurements on 481 men and women aged from 16 to 72 years. Br J Nutr 32:77–97
Berres F, Ulmer HV, Lamberty M (1980) Calculation of total body fat from skinfold thickness by using an age corrected formula. Pflugers Arch 384(Suppl):R35
von Restorff W (2004) Leitlinien der Deutschen Gesellschaft für Arbeitsmedizin und Umweltmedizin e.V. (DGAUM). https://www.dgaum.de/leitlinien-qualitaetssicherung. Zugegriffen am 01.02.2018
Schäffler A, Müller-Ladner U, Schölmerich J, Büchler C (2006) Role of adipose tissue as an inflammatory organ in human diseases. Endocr Rev 27:449–467
Beltowski J (2003) Adiponectin and resistin – new hormones of white adipose tissue. Med Sci Monit 9:RA55–RA61
Bowles L, Kopelman P (2001) Leptin: of mice and men? J Clin Pathol 54:1–3
Caro JF, Sinha MK, Kolaczynski JW, Zhang PL, Considine RV (1996) Leptin: the tale of an obesity gene. Diabetes 45:1455–1462
Chan JL, Mantzoros CS (2005) Role of leptin in energy-deprivation states: normal human physiology and clinical implications for hypothalamic amenorrhoea and anorexia nervosa. Lancet 366:74–85
Dardeno TA, Chou SH, Moon HS, Chamberland JP, Fiorenza CG, Mantzoros CS (2010) Leptin in human physiology and therapeutics. Front Neuroendocrinol 31:377–393
Kelesidis T, Mantzoros CS (2006) The emerging role of leptin in humans. Pediatr Endocrinol Rev 3:239–248
Cui J, Panse S, Falkner B (2011) The role of adiponectin in metabolic and vascular disease: a review. Clin Nephrol 75:26–33
Haluzik M, Parizkova J, Haluzik MM (2004) Adiponectin and its role in the obesity-induced insulin resistance and related complications. Physiol Res/Academia Scientiarum Bohemoslovaca 53:123–129
Han SH, Quon MJ, Kim JA, Koh KK (2007) Adiponectin and cardiovascular disease: response to therapeutic interventions. J Am Coll Cardiol 49:531–538
Kadowaki T, Yamauchi T (2005) Adiponectin and adiponectin receptors. Endocr Rev 26:439–451
Koerner A, Kratzsch J, Kiess W (2005) Adipocytokines: leptin – the classical, resistin – the controversical, adiponectin – the promising, and more to come. Best Pract Res Clin Endocrinol Metab 19:525–546
Haluzik M, Haluzikova D (2006) The role of resistin in obesity-induced insulin resistance. Curr Opin Investig Drugs 7:306–311
Barnes KM, Miner JL (2009) Role of resistin in insulin sensitivity in rodents and humans. Curr Protein Pept Sci 10:96–107
Chang YH, Chang DM, Lin KC, Shin SJ, Lee YJ (2011) Visfatin in overweight/obesity, type 2 diabetes mellitus, insulin resistance, metabolic syndrome and cardiovascular diseases: a meta-analysis and systemic review. Diabetes/Metab Res Rev 27:515–527
Sonoli SS, Shivprasad S, Prasad CV, Patil AB, Desai PB, Somannavar MS (2011) Visfatin – a review. Eur Rev Med Pharmacol Sci 15:9–14
Castaneda TR, Tong J, Datta R, Culler M, Tschop MH (2010) Ghrelin in the regulation of body weight and metabolism. Front Neuroendocrinol 31:44–60
Al Massadi O, Tschop MH, Tong J (2011) Ghrelin acylation and metabolic control. Peptides 32:2301–2308
Chen CY, Asakawa A, Fujimiya M, Lee SD, Inui A (2009) Ghrelin gene products and the regulation of food intake and gut motility. Pharmacol Rev 61:430–481
Tan BK, Adya R, Randeva HS (2010) Omentin: a novel link between inflammation, diabesity, and cardiovascular disease. Trends Cardiovasc Med 20:143–148
Ernst MC, Sinal CJ (2010) Chemerin: at the crossroads of inflammation and obesity. Trends Endocrinol Metab 21:660–667
Bluher M (2011) Vaspin in obesity and diabetes: pathophysiological and clinical significance. Endocrine 41:176–182
Compton SA, Cheatham B (2010) CTRP-3: blocking a toll booth to obesity-related inflammation. Endocrinology 151:5095–5097
Pfützner A, Forst T, Rancier M, Weryha G (2011) Metabolisches syndrom. Clinical and technical review. TECO medical Group, 1–31. https://www.dgaum.de/umweltmedizin. Zugegriffen am 01.02.2018
El-Mesallamy HO, El-Derany MO, Hamdy NM (2011) Serum omentin-1 and chemerin levels are interrelated in patients with Type 2 diabetes mellitus with or without ischaemic heart disease. Diabet Med 28:1194–1200
Akbarzadeh S, Nabipour I, Jafari SM, Movahed A, Motamed N, Assadi M, Hajian N (2012) Serum visfatin and vaspin levels in normoglycemic first-degree relatives of Iranian patients with type 2 diabetes mellitus. Diabetes Res Clin Pract 95:132–138
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer-Verlag GmbH Deutschland
About this chapter
Cite this chapter
Schäffler, A. et al. (2018). Fettgewebsdysfunktion. In: Schäffler, A. (eds) Funktionsdiagnostik in Endokrinologie, Diabetologie und Stoffwechsel. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-55914-7_17
Download citation
DOI: https://doi.org/10.1007/978-3-662-55914-7_17
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-55913-0
Online ISBN: 978-3-662-55914-7
eBook Packages: Medicine (German Language)